Political Science 1020E Study Guide - Quiz Guide: Condom, Drug User, Antibody
4 Jun 2018
School
Department
Course
Professor
MDGs
1. To have, by 2015, halted and begun to reverse the spread of HIV/AIDS.
2. To provide special assistance to children orphaned by HIV/AIDS.
3. To encourage the pharmaceutical industry to make essential drugs more widely
available and affordable by all those who need them in developing countries.
4. To help Africa build its capacity to tackle the spread of the HIV/AIDS pandemic
● Millennium Development Goal #6: Combat HIV/AIDS, malaria & other diseases
○ TARGET
■ Have halted by 2015 and begun to reverse the spread of HIV/AIDS.
○ TARGET
■ Achieve, by 2010, universal access to treatment for HIV/AIDS for all
those who need it.
Then Now Future
● New HIV infections
○ 2001: 3 mil
○ 2014: 2 mil
○ 2030: 0.2 mil
● AIDS-related deaths
○ 2004: 2 mil
○ 2014: 1.2 mil
○ 2030: 0.2 mil
● New HIV infections among children
○ 2001: 530, 000
○ 2014: 220, 000
○ 2030: <50, 000
● Children orphaned due to AIDS
○ 2009: 14.4 mil
○ 2014: 13.3 mil
○ 2030: 0 (more orphans, all orphans cared for and well)
● Awareness about HIV among young people
○ 2001: 25%
○ 2014: 35%
○ 2030: >90%
● Time it takes for an HIV test result
○ 2001: 3 days
○ 2014: 30 min
○ 2030: 3 min
● Countries that criminalize same-sex relationships
○ 2006: 92
○ 2014: 76
○ 2030: 0
● Number of pills taken by people living with HIV
○ 2001: 8 per day
find more resources at oneclass.com
find more resources at oneclass.com
Document Summary
Millennium development goal #6: combat hiv/aids, malaria & other diseases. Have halted by 2015 and begun to reverse the spread of hiv/aids. Achieve, by 2010, universal access to treatment for hiv/aids for all those who need it. 2030: 0 (more orphans, all orphans cared for and well) Time it takes for an hiv test result. Number of pills taken by people living with hiv. The male latex condom is the single, most efficient, available technology to reduce the sexual transmission of hiv . Reduce the risk of heterosexually acquired hiv among men by 60 percent. Recommended by the who and unaids as an effective prevention strategy. Detect anti-bodies produced in response to hiv. Results kept confidential in medical records, but not shared without permission. The tested person"s name is not used in connection with the test. No records are kept that would link the person to the test.
